Skip to main navigation
Home

Search form

  • About Us

    • Profile & Mission

    • Our Strategy

    • Leadership Team

    • Company Histroy

  • Our Products

  • Cumberland Emerging Technologies

  • Investor Relations

    Investor Relations

    • Investor Relations
    • Corporate Update
    • Corporate Governance
      • Board of Directors
      • Management
      • Committees
      • Contact the Board
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Events & Presentations
    • Investor FAQs
    • News Releases
      • Press Releases
      • Corporate Updates
      • In the News
    • Contact IR
    3 Mo. 6 Mo. 1 Yr.

    Shareholder Tools

    Search Investor Relations

  • News

  • Contact Us

    Corporate Headquarters

    Cumberland Pharmaceuticals Inc.
    2525 West End Avenue, Suite 950
    Nashville, Tennessee 37203

    Phone: (615) 255-0068
    Toll Free: (877) 484-2700
    Fax: (615) 255-0094

    info@cumberlandpharma.com

    *For directions to us, please see Location

    Employment Opportunities

    employment@cumberlandpharma.com

    Investor Relations

    investors@cumberlandpharma.com

    Business Development

    development@cumberlandpharma.com

    Wholesaler Customer Service

    Phone: (877) 274-7200
    Fax: (614) 652-9127

    Medical Information

    This website is not for medical emergencies. If you are a patient, caregiver or healthcare professional and need product related information, please visit our Products page, which will link you to product-specific websites.

    Adverse Event Reporting

    Toll Free Phone: (866) 767-5077
    (For healthcare professionals only)

     

     

Investor Relations

  • Investor Relations
  • Corporate Update
  • Corporate Governance
    • Board of Directors
    • Management
    • Committees
    • Contact the Board
  • Stock Information
    • Historic Stock Lookup
    • Analyst Coverage
    • Ownership Profile
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • Events & Presentations
  • Investor FAQs
  • News Releases
    • Press Releases
    • Corporate Updates
    • In the News
  • Contact IR
3 Mo. 6 Mo. 1 Yr.

Shareholder Tools

Search Investor Relations

 

Quarterly Results

Show all

2019

First Quarter
  • Cumberland Pharmaceuticals 2019 Q1 earnings call
  • Cumberland Pharmaceuticals Reports 38% Revenue Growth In The First Quarter
  • Form 10-Q

2018

Fourth Quarter
  • Cumberland Pharmaceuticals 2018 Q4 earnings call
  • Cumberland Pharmaceuticals Reports Fourth Quarter Revenue Growth Of 16%
  • Form 10-K
Third Quarter
  • Cumberland Pharmaceuticals 2018 Q3 earnings call
  • Cumberland Pharmaceuticals Reports Third Quarter 2018 Financial Results
  • Form 10-Q
Second Quarter
  • Cumberland Pharmaceuticals 2018 Q2 earnings call
  • Cumberland Pharmaceuticals Reports Second Quarter 2018 Financial Results
  • Form 10-Q
First Quarter
  • Cumberland Pharmaceuticals 2018 Q1 earnings call
  • Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results
  • Form 10-Q

2017

Fourth Quarter
  • Cumberland Pharmaceuticals 2017 Q4 earnings call
  • Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017
  • Form 10-K
Third Quarter
  • Cumberland Pharmaceuticals 2017 Q3 earnings call
  • Cumberland Pharmaceutical Reports 27% Revenue Growth In The Third Quarter
Second Quarter
  • Cumberland Pharmaceuticals 2017 Q2 earnings call
  • Cumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter
  • Form 10-Q
First Quarter
  • Cumberland Pharmaceuticals 2017 Q1 earnings call
  • Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017
  • Form 10-Q
Cumberland Pharmaceuticals Inc. 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203
Site MapPrivacy PolicyTerms & Conditions